<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03039972</url>
  </required_header>
  <id_info>
    <org_study_id>AZ 239/16</org_study_id>
    <nct_id>NCT03039972</nct_id>
  </id_info>
  <brief_title>Changes in Renal Function and Body Composition in Pulmonary Hypertension</brief_title>
  <official_title>Prospective Evaluation of Changes in Renal Function and Body Composition in Patients With Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Changes in renal function and body composition in patients with pulmonary hypertension
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective single-center study is designed to analyze changes in renal function and
      body composition in patients with suspected or pre-diagnosed pulmonary hypertension at
      pulmonary hypertension outpatient clinic, University Hospital Giessen and Marburg, Campus
      Giessen.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 25, 2017</start_date>
  <completion_date type="Actual">July 9, 2020</completion_date>
  <primary_completion_date type="Actual">October 7, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Changes in renal function in patients with pulmonary hypertension</measure>
    <time_frame>1 year</time_frame>
    <description>Estimated GFR based on Chronic Kidney Disease Epidemiology Collaboration-creatinine-cystatin C will be used to determine renal function at baseline and at 1 year follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in hydration status in patients with pulmonary hypertension</measure>
    <time_frame>1 year</time_frame>
    <description>Bioimpedance analysis will be used to determine hydration status at baseline and at 1 year follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in nutritional status in patients with pulmonary hypertension</measure>
    <time_frame>1 year</time_frame>
    <description>Bioimpedance analysis will be used to determine lean tissue and fat mass at baseline and at 1 year follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of baseline renal function, hydration and nutritional status on pulmonary hypertension-associated morbidity and mortality</measure>
    <time_frame>1 year</time_frame>
    <description>pulmonary hypertension-associated morbidity and mortality (defined as escalation of pulmonary hypertension-specific therapy, unscheduled hospitalization and all-cause mortality) will be prospectively assessed during follow-up period</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">412</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <condition>Renal Function Abnormal</condition>
  <arm_group>
    <arm_group_label>Pulmonary Hypertension</arm_group_label>
    <description>Adult outpatients with suspected or prediagnosed pulmonary hypertension irrespective of subclass and all chronic kidney disease stages</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Pulmonary Hypertension</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Collection of only residual material (blood, urine) for Deutsche Zentrum für Lungenforschung
      Biobank.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with suspected or pre-diagnosed pulmonary hypertension at pulmonary
        hypertension outpatient clinic, University Hospital Giessen and Marburg, Campus Giessen
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects older than 18 years at pulmonary hypertension outpatient clinic

          -  Subjects who signed informed consent forms

        Exclusion Criteria:

          -  Patients refusing to participate or withdraw consent during follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Werner Seeger, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Internal Medicine II, Division of Pulmonology, Nephrology and Critical Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Clinic Giessen and Marburg - Campus Giessen</name>
      <address>
        <city>Giessen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Bellomo R, Prowle JR, Echeverri JE. Diuretic therapy in fluid-overloaded and heart failure patients. Contrib Nephrol. 2010;164:153-163. doi: 10.1159/000313728. Epub 2010 Apr 20. Review.</citation>
    <PMID>20428001</PMID>
  </reference>
  <reference>
    <citation>Ronco C, Verger C, Crepaldi C, Pham J, De Los Ríos T, Gauly A, Wabel P, Van Biesen W; IPOD-PD Study Group. Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)†. Nephrol Dial Transplant. 2015 May;30(5):849-58. doi: 10.1093/ndt/gfv013. Epub 2015 Mar 11.</citation>
    <PMID>25762355</PMID>
  </reference>
  <results_reference>
    <citation>Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV Jr, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May;9(5):855-63. doi: 10.2215/CJN.10191013. Epub 2014 Feb 27.</citation>
    <PMID>24578332</PMID>
  </results_reference>
  <results_reference>
    <citation>Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009 Feb 17;53(7):582-588. doi: 10.1016/j.jacc.2008.08.080.</citation>
    <PMID>19215832</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 29, 2017</study_first_submitted>
  <study_first_submitted_qc>January 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Giessen</investigator_affiliation>
    <investigator_full_name>Faeq Husain</investigator_full_name>
    <investigator_title>Senior Physician Nephrology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Starting 6 months after publication</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

